Sepsis Diagnostic Market: By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), By Method (Conventional Diagnostics and Automated Diagnostics), By Test Type (Laboratory Tests and Point-Of-Care Tests), By End User (Hospitals, Pathology & Reference Laboratories) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Sepsis Diagnostic Market size was valued at USD 585.82 million in 2022 and is poised to grow at a CAGR of 7.62% from 2023-29. Due to increase in prevalence of sepsis which may lead to organ dysfunction and acute alteration in mental status and even it may cause death in severe cases. Moreover, the different procedures of treatment that can cause sepsis are also increasing, and rise in R&D activities for the development of sepsis diagnostics are the major factors that are driving the growth of the global market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global sepsis diagnostic market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global sepsis diagnostic market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global sepsis diagnostic products.

Global Sepsis Diagnostic Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.62%

Largest Market

North America

Fastest Growing Market

Europe
Sepsis Diagnostic Market Dynamics

Increase in the prevalence of sepsis is a key factor drive the global sepsis diagnostic market. According to World Health Organization 2018, approximately 6 Mn death occurred due to sepsis around the globe. Moreover, the raise in funding for the R&D activities by public and private sectors, growing healthcare awareness and health care spending and the occurrence of Hospital Acquired Infection are anticipated to propel the global sepsis diagnostic market over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

Global Sepsis Diagnostic Market Segmentation

By Technology
  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
By Product
  • Blood Culture Media
  • Instruments
  • Assays & Reagents
By Pathogen
  • Bacterial Sepsis
  • Gram-negative Bacterial Sepsis
  • Gram-positive Bacterial Sepsis
  • Fungal Sepsis
  • Others
By Type Analysis
  • Laboratory Tests
  • Point-Of-Care Tests

Frequently Asked Questions

The key segments covered in the sepsis diagnostic market are: by technology, pathogen type, method and geography

The sepsis diagnostic market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The sepsis diagnostic market key players are: Roche Diagnostics (Switzerland), Becton, Dickinson and Company (U.S.), Abbott (US), bioMérieux (France), Danaher (US), Luminex (US),  Immunexpress (US), Cepheid Inc (United States)

1. Executive Summary
2. Global Sepsis Diagnostic Market Introduction 
2.1.Global Sepsis Diagnostic Market  - Taxonomy
2.2.Global Sepsis Diagnostic Market  - Definitions
2.2.1.Technology
2.2.2.Product
2.2.3.Pathogen
2.2.4.Type Analysis
2.2.5.Region
3. Global Sepsis Diagnostic Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Sepsis Diagnostic Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Sepsis Diagnostic Market  By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Microbiology
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Molecular Diagnostics
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Immunoassays
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Flow Cytometry
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Sepsis Diagnostic Market  By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Blood Culture Media
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Instruments
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Assays & Reagents
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Sepsis Diagnostic Market  By Pathogen, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Bacterial Sepsis
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Gram-negative Bacterial Sepsis
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Gram-positive Bacterial Sepsis
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Fungal Sepsis
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Sepsis Diagnostic Market  By Type Analysis, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Laboratory Tests
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Point-Of-Care Tests
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9. Global Sepsis Diagnostic Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Microbiology
10.1.2.Molecular Diagnostics
10.1.3.Immunoassays
10.1.4.Flow Cytometry
10.3.  Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Bacterial Sepsis
10.3.2.Gram-negative Bacterial Sepsis
10.3.3.Gram-positive Bacterial Sepsis
10.3.4.Fungal Sepsis
10.3.5.Others
10.4.  Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Laboratory Tests
10.4.2.Point-Of-Care Tests
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Microbiology
11.1.2.Molecular Diagnostics
11.1.3.Immunoassays
11.1.4.Flow Cytometry
11.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Blood Culture Media
11.2.2.Instruments
11.2.3.Assays & Reagents
11.3.  Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Bacterial Sepsis
11.3.2.Gram-negative Bacterial Sepsis
11.3.3.Gram-positive Bacterial Sepsis
11.3.4.Fungal Sepsis
11.3.5.Others
11.4.  Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Laboratory Tests
11.4.2.Point-Of-Care Tests
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Microbiology
12.1.2.Molecular Diagnostics
12.1.3.Immunoassays
12.1.4.Flow Cytometry
12.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Blood Culture Media
12.2.2.Instruments
12.2.3.Assays & Reagents
12.3.  Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Bacterial Sepsis
12.3.2.Gram-negative Bacterial Sepsis
12.3.3.Gram-positive Bacterial Sepsis
12.3.4.Fungal Sepsis
12.3.5.Others
12.4.  Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Laboratory Tests
12.4.2.Point-Of-Care Tests
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.  Middle East and Africa (MEA) Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Microbiology
13.1.2.Molecular Diagnostics
13.1.3.Immunoassays
13.1.4.Flow Cytometry
13.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Blood Culture Media
13.2.2.Instruments
13.2.3.Assays & Reagents
13.3.  Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Bacterial Sepsis
13.3.2.Gram-negative Bacterial Sepsis
13.3.3.Gram-positive Bacterial Sepsis
13.3.4.Fungal Sepsis
13.3.5.Others
13.4.  Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Laboratory Tests
13.4.2.Point-Of-Care Tests
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Sepsis Diagnostic Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Microbiology
14.1.2.Molecular Diagnostics
14.1.3.Immunoassays
14.1.4.Flow Cytometry
14.2.  Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Blood Culture Media
14.2.2.Instruments
14.2.3.Assays & Reagents
14.3.  Pathogen Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Bacterial Sepsis
14.3.2.Gram-negative Bacterial Sepsis
14.3.3.Gram-positive Bacterial Sepsis
14.3.4.Fungal Sepsis
14.3.5.Others
14.4.  Type Analysis Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Laboratory Tests
14.4.2.Point-Of-Care Tests
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Roche Diagnostics (Switzerland)
15.2.2.Becton, Dickinson and Company (U.S.)
15.2.3.Abbott (US)
15.2.4.bioMérieux (France)
15.2.5.Danaher (US) Luminex (US)
15.2.6. Immunexpress (US)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Roche Diagnostics (Switzerland)
  • Becton, Dickinson and Company (U.S.)
  • Abbott (US)
  • bioMérieux (France)
  • Danaher (US) Luminex (US)
  •  Immunexpress (US)
  • Cepheid Inc (United States)
  • Bruker (U.S)
  • Quidel Corporation (U.S.)

Adjacent Markets